The Philippines is the ninth country to grant the EUA to Covaxin, which has an 81% efficacy rate and is a traditional inactivated whole virion vaccine. It is the first indigenously-developed COVID-19 vaccine in India by Bharat Biotech in collaboration with the Indian Council of Medical Research. Covaxin has been safely used by millions of people in India’s COVID-19 vaccination program, with numerous government officials such as the Prime Minister Narendra Modi having received doses of Covaxin in a national campaign to thwart vaccine hesitancy. Ambitech and Go Negosyo have an ongoing collaboration to make Covaxin available to the private sector and msme's. We believe making vaccines inclusive to the msme sector will help revitalize our economy," Abichandani said.

Source: Philippine Star April 20, 2021 09:56 UTC